Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A series of novel N(4)-(hetero)arylsulfonylquinoxalinone derivatives were prepared in a straight and efficient way. Of all the synthesized compounds, five compounds exhibited potent anti-HIV-1 replication activities with IC(50) value at the level of 10(-7) mol/L. Preliminary structure-activity relationships were studied in details and that will shed light on the discovery of more potent non-nucleoside reverse-transcriptase inhibitors.

DOI： 10.1016/j.bmc.2009.02.039

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2009.0
Synthesis and biological evaluation of novel quinoxalinone-based HIV-1 reverse transcriptase inhibitors
Med. Chem. Commun. 2013.0
Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis and anti-HIV activity evaluation of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio]acetohydrazides
Medicinal Chemistry Research 2010.0
Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme
European Journal of Medicinal Chemistry 2020.0
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry Letters 2000.0
Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2014.0